Breadcrumb
NIH Guide: Weekly Index for April 14, 2023
Weekly NIH Funding Opportunities and Notices
April 14, 2023
General Notices
-
Request for Information (RFI): Understanding the Creation, Continuation, and Consequences of Illicit Drug Markets
(NOT-DA-23-023)National Institute on Drug Abuse
-
Request for Information (RFI): Food is Medicine Research Opportunities
(NOT-OD-23-107)Office of Nutrition ResearchAgency for Healthcare Research and QualityNational Institute on AgingNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthOffice of the Director, NIHNational Center for Complementary and Integrative HealthOffice of Research on Women's HealthOffice of Dietary SupplementsOffice of AIDS ResearchFood and Drug AdministrationOffice of Disease PreventionNational Institute on Minority Health and Health Disparities
Notice of Changes to Funding Opportunities
-
Notice of Early Expiration of PAR-21-112, "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)"
(NOT-AG-23-019)National Institute on Aging
-
Notice of Change in Funding Opportunity Purpose of NIDCR Small Research Grants for Analyses of Existing Genomics Data (PAR-23-132)
(NOT-DE-23-009)National Institute of Dental and Craniofacial Research
-
Notice to update Section IV. Application and Submission Information - Specific Aims and Research Strategy: for PAR-21-178 - Drug Development Tools Research Grants (U01) Clinical Trial Optional
(NOT-FD-23-009)Food and Drug Administration
-
Notice to Extend the Application Due Date for RFA-FD-23-019 - Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
(NOT-FD-23-010)Food and Drug Administration
-
Notice to Extend the Application Due Date for RFA-FD-23-027- Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed
(NOT-FD-23-011)Food and Drug Administration
-
Notice of Change of the Locus of Review, Application Types Allowed and Expiration date for PAR-23-097, "Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)"
(NOT-MH-23-205)National Institute of Mental Health
-
Notice of Change of the Locus of Review for PAR-23-102, "Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)"
(NOT-MH-23-206)National Institute of Mental Health
-
Notice of Termination of PAR-22-100 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
(NOT-TR-23-008)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
-
Notice of Termination of PAR-22-101 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
(NOT-TR-23-009)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Notices of Intent to Publish
-
Notice of Intent to Publish a Notice of Funding Opportunity for the PATCH-IN Implementation Science Coordinating Center (UM2 Clinical Trial Optional)
(NOT-HD-23-009)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
(NOT-HG-23-034)National Human Genome Research Institute
-
Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
(NOT-HG-23-035)National Human Genome Research Institute
Notices of Special Interest
-
Notice of Special Interest (NOSI): Assembling the Addiction Organelle Interactome
(NOT-DA-24-007)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications.
(NOT-EB-23-002)National Institute of Biomedical Imaging and BioengineeringNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of General Medical SciencesNational Cancer InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Center for Complementary and Integrative Health
-
Notice of Special Interest (NOSI): EXposome in Autoimmune Disease Collaborating Teams PLANning Awards (EXACT-PLAN) (Clinical Trials Not Allowed)
(NOT-OD-23-112)National Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on AgingNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Center for Complementary and Integrative HealthOffice of Research on Women's Health
Funding Opportunities
-
Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
(PAR-23-098)National Human Genome Research InstituteNational Institute of Mental HealthApplication Receipt Date(s): June 22, 2025
-
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
(PAR-23-119)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): January 7, 2025
-
Development and Validation of Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed)
(PAR-23-154)National Institute of Neurological Disorders and StrokeNational Institute on AgingApplication Receipt Date(s): October 20, 2023
-
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
(PAR-23-155)National Cancer InstituteApplication Receipt Date(s): August 9, 2023
-
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
(PAR-23-157)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)
(PAR-23-158)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
(PAR-23-159)National Center for Advancing Translational SciencesNational Center for Advancing Translational SciencesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): October 17, 2024
-
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
(PAR-23-160)National Center for Advancing Translational SciencesNational Center for Advancing Translational SciencesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): October 17, 2024
-
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
(PAR-23-163)National Institute on AgingApplication Receipt Date(s): September 25, 2023
-
Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
(PAR-23-171)National Institute of Neurological Disorders and StrokeNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Center for Advancing Translational SciencesNational Center for Advancing Translational SciencesApplication Receipt Date(s): May 15, 2025
-
International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
(RFA-AI-23-023)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Strengthening Global Competency and Capacity in Inspectional Approaches for the Oversight of Human and Animal Pharmaceutical Products (U01) Clinical Trials Not Allowed
(RFA-FD-23-022)Food and Drug AdministrationApplication Receipt Date(s): June 20, 2023
-
Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional)
(RFA-MH-23-105)National Institute of Mental HealthApplication Receipt Date(s): June 14, 2023
-
Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH): Data Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-MH-23-106)National Institute of Mental HealthApplication Receipt Date(s): June 14, 2023
-
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
(RFA-MH-23-270)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): June 7, 2024
-
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)
(RFA-MH-23-330)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): Multiple dates, see announcement.
-
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
(RFA-MH-23-331)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): Multiple dates, see announcement.
-
Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed)
(RFA-TR-23-010)National Center for Advancing Translational SciencesNational Center for Advancing Translational SciencesNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthApplication Receipt Date(s): May 22, 2023
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: February 14, 2025
For technical issues E-mail OER Webmaster